Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HumanaHUM -0.60%84 EV-to-EBIT is 22.45 as of Aug. 18, 2026, which is 57% above its 10-year median of 14.32. GuruFocus rates HUM with a GF Score™ of 84/100 and a GF Value™ of $369.90 (Fairly Valued). The stock has 6 warning signs investors should review. Among 15 Healthcare Plans companies, Humana ranks worse than 73.33% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Humana's Enterprise Value is $53,289 Mil.
Humana's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $2,374 Mil. Therefore, Humana's EV-to-EBIT for today is 22.45.
The historical rank and industry rank for Humana's EV-to-EBIT or its related term are showing as below:
HUM'
s EV-to-EBIT Range Over the Past 10 Years
Min: 8.75 Med: 14.32 Max: 26.1
Current: 22.45
During the past 13 years, the highest EV-to-EBIT of Humana was 26.10. The lowest was 8.75. And the median was 14.32.
HUM's EV-to-EBIT is ranked worse than 73.33% of 15
companies
in the Healthcare Plans industry
Industry Median: 18.96
vs HUM: 22.45
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Humana's Enterprise Value for the quarter that ended in Jun. 2026 was $55,116 Mil.
Humana's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,374 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humana EV-to-EBIT Related Terms
Humana EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Humana's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Humana's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humana EV-to-EBIT vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Humana's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Humana's EV-to-EBIT falls into.
Humana's current Enterprise Value is $53,289 Mil.
Humana's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,374 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humana (HUM) has a EV-to-EBIT of 22.45 as of Aug. 18, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Humana and its competitors. This is 57% above median its historical median of 14.32. Over the past decade, Humana's EV-to-EBIT has ranged from 8.75 to 26.10. According to the industry distribution chart, Humana ranks #11 out of 15 companies in the Healthcare Plans industry, placing it in the top 73.3%.
Is Humana's EV-to-EBIT too high?
Humana's current EV-to-EBIT of 22.45 is 57% above median its 10-year median of 14.32. Over the past 10 years, this metric has ranged from a low of 8.75 to a high of 26.10. The Healthcare Plans industry median EV-to-EBIT is 18.96. Humana's value of 22.45 is 18.4% above this industry median. Based on the distribution chart, Humana ranks #11 out of 15 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Humana has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Humana's EV-to-EBIT compare to CNC and CI?
According to the Healthcare Plans industry distribution chart, Humana ranks #11 out of 15 companies for EV-to-EBIT. This places Humana in the lower half of its industry. The industry median EV-to-EBIT is 18.96. Humana's value of 22.45 is 18.4% above this benchmark. Historically, Humana's own EV-to-EBIT has ranged from 8.75 to 26.10 over the past decade. While the company's 10-year median is 14.32 vs. the industry median of 18.96, Humana has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Plans company?
The median EV-to-EBIT among Healthcare Plans companies is 18.96, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humana's current EV-to-EBIT of 22.45 is 18.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Humana and its competitors. For the Healthcare Plans industry, the median EV-to-EBIT is 18.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humana's current EV-to-EBIT is 22.45, which is 57% above median its own 10-year median of 14.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana stock overvalued right now?
Based on GuruFocus' analysis, Humana (HUM) is currently considered Fairly Valued. The stock's GF Value™ is $369.90, compared to a current price of $382.00 — trading 3.3% above its estimated fair value. The current EV-to-EBIT is 22.45, which is 57% above median its 10-year median of 14.32 and 18.4% above the Healthcare Plans industry median of 18.96. Humana's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Humana (HUM), the current EV-to-EBIT is 22.45 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humana (HUM) Overvalued in 2026?
Based on GuruFocus' analysis, Humana stock appears to be overvalued.
The current stock price of $382.00 is trading 3.3% above its estimated GF Value™ of $369.90.
GuruFocus considers Humana to be Fairly Valued.
Key valuation signals for HUM:
EV-to-EBIT: 22.45 (57% above median its 10-year median of 14.32)
GF Value™: $369.90 vs. price of $382.00 (3.3% above fair value)
Industry Position: 18.4% above the Healthcare Plans median (#11 of 15)
No single metric tells the full story. See the HUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
84GF Score
Get the complete analysis for HUM
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HUM has been successfully added to your 
